Guardant Health (GH) Cost of Revenue (2024 - 2026)

Guardant Health has disclosed Cost of Revenue across 3 years of filings, most recently posting $115.9 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 42.79% year-over-year to $115.9 million; the TTM figure through Jun 2026 stood at $413.9 million (up 34.39% YoY), while the FY2025 annual figure was $349.0 million, up 20.43% from the prior year.
• Cost of Revenue came in at $115.9 million for Q2 2026 at Guardant Health, up from $104.9 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $115.9 million in Q2 2026 to a low of $65.3 million in Q1 2024.
• Average Cost of Revenue over 3 years is $86.0 million, with a median of $79.4 million recorded in 2024.
• Year-over-year, Cost of Revenue increased 12.13% in 2025 and soared 42.79% in 2026.
• Over 3 years, Cost of Revenue stood at $77.6 million in 2024, then gained by 28.22% to $99.5 million in 2025, then advanced by 16.54% to $115.9 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $115.9 million in Q2 2026, $104.9 million in Q1 2026, and $99.5 million in Q4 2025.